Indivior Pharmaceuticals Inc (INDV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -9M | -221M | -39M | 166.04M | 75M | -5.65M | 8M | 87.83M | -54.76M | -279.72M | 21.17M | -19.83M |
| Operating CF Margin % | -2.84% | -61.73% | -12.42% | 54.98% | 28.2% | -1.89% | 2.61% | 29.37% | -19.28% | -95.47% | 7.81% | -7.19% |
| Operating CF Growth % | -112% | -3813.34% | -587.5% | 89.05% | 236.97% | 97.98% | -62.21% | 542.84% | -52.1% | -1558.38% | -64.43% | -169.46% |
| Net Income | 89M | 102M | 43M | 18M | 47M | 20M | 3M | -107.22M | 46.79M | 54M | -135M | 39M |
| Depreciation & Amortization | 4M | 5M | 5M | 5M | 5M | 0 | -10M | 6M | 8.96M | 9M | 7M | 6M |
| Stock-Based Compensation | 9M | 5M | 7M | 8M | 6M | 0 | 7M | 5M | 5M | 0 | 0 | 0 |
| Deferred Taxes | 27M | -36M | -15M | 0 | 0 | 6.02M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -138M | 5.45M | 18M | 9.65M | 0 | 93.98M | 49M | -5.95M | -34.87M | 23.88M | -62.25M | 22.39M |
| Working Capital Changes | 0 | -302.45M | -97M | 126.18M | 17M | -125.65M | -41M | 190M | -80.64M | -366.59M | 211.42M | -87.23M |
| Change in Receivables | 0 | 6.11M | -18M | 4.45M | 11M | -4.06M | 9M | -10.98M | 4.98M | -6.43M | -18.39M | -15.12M |
| Change in Inventory | 0 | 1.74M | -6M | 17.66M | 5M | -8.47M | -7M | -8.05M | -20.91M | 5.55M | -15.34M | -6.17M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 3.59M | 55.01M | 12.94M | 22M | 31.87M | 30.91M |
| Cash from Investing | -19M | -24M | -20M | -18.69M | -5M | 9.12M | 32M | 1M | 24.89M | 8.23M | -1.47M | 22.44M |
| Capital Expenditures | -20M | -24M | -20M | -18.69M | -5M | -15.82M | -7M | -4M | -1.99M | -17.21M | -28.58M | -1.11M |
| CapEx % of Revenue | 6.31% | 6.7% | 6.37% | 6.19% | 1.88% | 5.29% | 2.28% | 1.34% | 0.7% | 5.87% | 10.55% | 0.4% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.32M | -544.94K | -1.88M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 6M | 0 | 0 | 1M | -1M | 0 | -3.85M | -887.27K | 0 | 0 | 0 | 0 |
| Cash from Financing | 7M | -5M | -3M | -4.63M | -17M | 29.07M | -55M | -34.78M | -37.83M | -20.42M | -1.13M | -2.36M |
| Debt Issued (Net) | 0 | -4.84M | -4M | -4.24M | -4M | 2.04M | -1M | 0 | -3M | 12.23M | -1.07M | -166.62K |
| Equity Issued (Net) | 0 | 156.03K | 2M | -300.98K | -10M | -48.3M | -51M | -34M | -36M | -21.81M | 2M | -136.32K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -126M | 190.71K | 0 | -331.08K | -11M | -49.27M | -52M | -34M | -35.84M | -21.72M | -48.34K | -166.62K |
| Other Financing | 7M | -318.55K | -1M | -90.29K | -3M | 75.33M | -3M | -778.2K | 1.17M | -10.85M | -2.06M | -2.06M |
| Net Change in Cash | -20M | -250M | -65M | 138M | 53M | 31M | -14M | 54.23M | -67.74M | -294M | 18M | 4M |
| Free Cash Flow | -29M | -245M | -59M | 148.38M | 70M | -21.49M | -1M | 83.83M | -56.75M | -283.62M | 19.12M | -20.86M |
| FCF Margin % | -9.15% | -68.44% | -18.79% | 49.13% | 26.32% | -7.19% | -0.33% | 28.04% | -19.98% | -96.8% | 7.06% | -7.56% |
| FCF Growth % | -141.43% | -1039.85% | -5800% | 77.01% | 223.36% | 92.42% | -105.23% | 501.78% | -35.11% | -1484.73% | -66.87% | -178.39% |
| FCF per Share | -0.22 | -1.96 | -0.46 | 1.20 | 0.57 | -0.17 | -0.01 | 0.62 | -0.41 | -2.00 | 0.14 | -0.15 |
| FCF Conversion (FCF/Net Income) | -0.10x | -2.17x | -0.93x | 9.22x | 1.60x | -0.10x | 2.00x | -0.91x | -0.90x | -5.18x | -0.16x | -0.51x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |